Coverage by Quantum Confidential!
America's baby boomers - a group 91 million strong - are waking up to the reality that they'll need over $1 million in their retirement fund to continue the easy-living lifestyle they have grown accustomed to. It's a retirement crisis of epic proportion.
But there's a small minority that's well on their way to doubling their million-dollar minimum.
Discover the secret to pulling in 950% gains - and keep your portfolio earning for years to come.
Dear Investor,
Dr. Mark W. leads a lifestyle to be envied by many - golf vacations, beach house, a nest egg that leaves him worry free. Rumors of Social Security going broke by 2042 and increasing cost of living estimates . . . don't faze him in the slightest.
Why? Because he knew the tell-tale signs of a winning tech play long before most investors.
Dr. Mark bought $10,000 worth of stock at $13.51 a share.
A year later the stock was at $19.49. If he sold, he'd pocket a tidy $4,422.60. Nice 44% gain, better than some of his other investments.
Something told him to hold on, though. He had other plays going, and his gut told him this stock hadn't even begun to show its value. He bought another $10,000 worth.
He held on, and watched the stock climb. And climb. And climb.
Four years after his initial investment, the stock stood at $141.91. That's not a typo: it was trading at pennies shy of one hundred and forty-two dollars a share. And here's where Dr. Mark stood:
His initial $10,000 was now worth $105,013.40. That's a profit of more than $95,000 and a gain of more than 950%.
His second ten grand was now worth $72,799.83 - another nice profit of almost $63,000.
Altogether, if Dr. Mark sold everything today he would pocket $157,813.23.
Dr. Mark W. had invested in a radical new surgical procedure - using robotics to perform the most sensitive, minimally invasive operations. It had implications far beyond the battlefield for which it was developed. It would revolutionize surgery as he knew it.
As a doctor and an investor, he saw long before Wall Street just how revolutionary and world-changing this robotic surgical system would be.
The robotic system is called Da Vinci. The company is called Intuitive Surgical:
Dr. Mark is holding on to his stock. The dividends have funded a nice nine-bedroom beachfront vacation house, and he's planning to get a ten-year head start on retirement.
While Dr. Mark reaps his rewards, a lot of players out there shake their heads. How could they have missed this incredible opportunity?
"Wealth Care" - The Million-Dollar Minimum You Need to Make Now
As little as a generation ago, people didn't expect to live much beyond the normal retirement age of 65. Social Security, a company pension, and modest savings - the proverbial three-legged stool - were usually enough to see most people through.
But today, assuming good health, you easily have 20 more years to enjoy the lifestyle of your dreams. Charter a sailboat down to the Caribbean, build that wine cellar you've always wanted, or simply sip a fine port by the fireplace at your Jackson Hole vacation home - where your annual ski trip has developed a following among friends and family.
The Boomers face a retirement crisis of epic proportions.
There are about 91 million of us in the U.S. today. And using even the most conservative "income replacement" figures and Census Bureau HHI data, each of us is going to need about $910,000 - minimum - to survive into our 80s.
Over 900 grand just to survive, mind you.
And since costs never go down, we can easily round that up to a cool million.
Most Americans aren't anywhere close. Most report they've saved less than $50,000. And almost one-half of those have saved less than $25,000 toward retirement.
So 91 million of us are going to need about a million apiece starting in just a few years. And that's about $91 billion that we are nowhere near putting aside.
But there's a small minority that's well on their way to doubling their million-dollar minimum, ready for a "retirement" that's all about living and living well.
Dr. Mark is in that minority.
That's because Dr. Mark understands our country's "Wealth Care System."
Forget the three legs of that three-legged stool. They're never going to support you.
So what will? What does Dr. Mark have that so many others don't?
Knowledge - that's how you care for your wealth.
It's all about the how much you know and from whom you learn it.
It's how can you turn a $10,000 investment into $105,000, like Dr. Mark.
Dr. Mark has the connections and insight that lets him recognize a sure-fire biotech winner. And he did - to the tune of a 950% gain. And that's just one of the many knowledge-based winners in his portfolio, I'm sure.
If you want to avoid the coming retirement crisis and secure a nice tidy nest egg allowing for a perpetual cash flow, you have to have knowledge above and beyond what's reported or purported in the media, the investment blogs, and all the other "outside" sources. It's all old news.
Remember - Dr. Mark held on to his stock even after a 44% gain. Something told him to hold.
Sure, he had his own gut instincts. He's a smart guy. His instincts made him a very successful doctor.
But instincts only take you so far. You need something else.
The power of knowledge.
That's the power of Quantum Confidential.
To Get the Expert Knowledge, Know the Experts
Right now, there's another biotech play doctors are talking about just waiting to balloon like Intuitive. It's just a matter of time for this biotech blockbuster.
The stock's been on the market only a short time. It has yet to close below its IPO list. It's seen modest gains over the past few months, but those gains aren't going to stay modest forever. They're going to bust out. And soon.
For Wall Street, this company's still under the radar. But for hospitals around the world - and savvy investors here at home - it's right in the center of the screen.
If you get in now you stand to profit just as much - if not more - than the smart docs who got into Intuitive in its early days.
But this company isn't just going to fatten your portfolio. It's going to change what we mean by "surgery." It's going to change how the world thinks about disease and pain and healing.
In just three and a half years, this tumor-tracking cancer killer has treated over 30,000 cancer patients suffering from nearly every type of cancer known. But I'll tell you more about that in a minute.
Right now I want to tell you about the lung cancer patients this miracle tumor tracker has healed. More than 2,000 lung cancer patients in just over three and a half years.
Do cancer tumors move? You bet they do. Every time you breathe, everything in you moves.
And every time you move, you shift the position of the tumor you're trying to hit. It becomes a moving target.
On a lung that target moves a lot. If you miss . . . depending on where the tumor's located . . . that could mean permanent damage. Or worse.
But fortunately, lung cancer patients can be treated with futuristic technology so completely revolutionary that it tracks the microscopic movements of the tumor in real time and allows the radiation beam to pinpoint the tumor at any given point in time and space.
The new technology takes the slightest involuntary movement into account, adjusts for it, and homes in on the cancer.
This Biotech Blockbuster Saves Lives
Like Joan S. She was diagnosed with Stage IV cancer in both lungs. She had her first lung tumor removed using traditional surgery. The long, painful recovery that followed convinced her to have the second tumor removed non-invasively using this astonishing new biotech marvel. "The treatment was very easy," she reported. "I relaxed and slept during the treatment and was able to return to work immediately. I had no side effects and I am grateful" for this revolution in healing.
Or Nancy K., 51. She chose to have her lung cancer treated with this biotech blockbuster. She had to have two procedures to completely destroy the tumors that had spread to her chest area, but the non-invasive, painless treatment helped her regain her energy and strength.
"I felt pretty great afterward," Nancy said. "I walked through plenty of malls and chased after my grandbabies. You would have never known I ever had cancer."
Or Bruce in Florida. Diagnosed with lung cancer at age 68. Chemo shrank the size of the tumor but didn't kill it. So he got on the waiting list behind 40 other cancer patients to take advantage of this surgical breakthrough. He's done the first of three sessions, and when it's over, he expects to be completely cancer-free.
As one doctor states, this "is the first and only radiosurgery treatment that can precisely target a number of lung tumors without invasive procedures, debilitating side effects or a long, painful recovery period."
In other words, for once the cure isn't worse than the disease.
Cancer's not going to go away, not in my lifetime, anyway - or yours, for that matter. But how to treat it is going to be a very, very big part of our lives.
Get Ready For the Medical Technology Spending Boom
Let's run a few numbers. Some good. Some not so good.
You know we're getting older. And by "we," of course, I'm talking about you and me - Baby Boomers. Right now we're about 30% of the U.S. population.
The first of us Boomers are going to reach 65 in 2011 - four short years away. And the rest of us aren't far behind.
And that makes all of us prime targets for, among other things, cancer.
Half a million estimated cancer deaths in the U.S. last year. 564,830 is what the government's saying, and that's ballpark.
But let's break it down:
Now, I don't want to come off hard-boiled and cynical. But I have to look at it this way. Sure, it's a miraculous piece of technology. But if there's no market, then frankly there's no need to invest. There sure as heck wouldn't be any need for me to ask you to get as excited about this company as I am.
So let's all be grownups about this.
Even the most modern radiation treatments can only really address brain cancers. And that was the smallest category of U.S. cancer deaths last year.
Again, I'm not trying to be cynical. Every brain tumor successfully eliminated is a gift beyond any monetary measurement.
But a market that small doesn't make for the kind of biotech blockbuster I'm talking about. It certainly wouldn't make you enough to successfully retire on. It won't solve your "wealth care" problems.
Look, these modern radiation treatments can't help anyone suffering from breast cancer, liver cancer, pancreatic cancer, prostate cancer or lung cancer.
Add those numbers up. 279,280 cancer cases. Just about half of all cancer deaths in the U.S. last year were in these five categories.
In fact, there were twelve times as many cases of lung cancer as brain cancer.
The American Cancer Society says lung cancer alone is going to be responsible for 29 percent of all cancer deaths in 2007.
And here's another unpleasant surprise: each year almost twice as many women die from lung cancer as from breast cancer.
The doctor who invented this tumor terminator - and launched this biotech "doctor's retirement plan" - figured out how to treat inoperable lung, breast, liver, pancreatic, prostate and, oh yes, brain cancers all with his miraculous device.
And guess who's going to get these cancers? We are.
Look at what's happening to us Boomers over the next ten to 15 years:
Think about it. Three years from now, nearly one million cancer cases. Just about all of them treatable with the new miracle tumor tracker.
Hospitals know where this is going. A few years ago, per capita hospital spending was projected to increase 75% between 2002 and 2012. We're smack dab in the middle of that trend.
And medical technology like my guy's miracle tumor tracker is behind it all. We're in the middle of a medical technology spending boom. One study spelled it out: "The main force driving spending is technology."
Look, hospitals are chronically risk-averse. CFOs don't spend unless they're fairly certain they're going to see a nice return on their investment. So when I read that hospitals that already own one of these $5 million miracle machines are putting in orders for more, I figure they're on to something.
If you can make $XX,XXX,XXX with one machine, you can easily double it with two.
And speaking of doubling, when I read that hospitals have doubled ad expenditures since 2001, I know they're on to something. And guess what? They're advertising our miracle tumor-tracker.
Follow the money.
I'm Brian Hicks, publisher of Quantum Confidential.
Tech stocks - biotech stocks in particular - are the major drivers of a world-changing revolution.
This tech revolution will be lead by companies like the one we've added to the Quantum Confidential portfolio and featured in the special report The Next Intuitive Surgical that I have put together for you.
You see, I believe this tumor-tracking biotech company has the blockbuster potential to make the kind of long-term gains that will let you build a nice nine-bedroom beachfront vacation house anywhere you like . . . you just have to pick the beach.
How do we know?
Simple - we follow the medical money. You see, doctors know the tell-tale signs of a winning tech play. Our analysts network extensively in the medical investment community, digging deep into the plays the docs are putting their investment dollars behind.
And they don't play for little gains. They get in for the long haul and play for the big money.
So do we. We follow the tech money wherever it goes - in the hospital, on the battlefield, in the vehicle dashboard, all the way down to subatomic level.
You see, at the heart of the technology revolution we're living through is one thing:
Knowledge. The kind of knowledge that changes the world. The kind of knowledge that drives our research analysts out into the field every day to deliver groundbreaking opportunities that will change our lives.
And the single most important thing you can do to make sure you give yourself a rich and rewarding retirement fund is to put the knowledge of our Quantum Confidential experts to work for you.
put the quantum confidential experts to work for you
"I Wouldn't Be Alive Today . . ."
Her name is Karen. Mid thirties, lives in a thriving southwestern U.S. metropolis with her adoring husband and adorable five-year-old son.
And completely blind. Not because of a birth defect or workplace accident. Blind because of an inoperable tumor that has been pressing down on her brain for three years.
She hasn't seen her son in three years.
And by "inoperable" I mean just that. No conventional surgery can adequately remove the malignant tumor. And two years of chemo treatment have had no effect at all (unless you count constant fatigue and hair loss).
So what is Karen's future? A bleak one of increasing pain, growing psychosis, and eventually death?
Maybe. But her doctors are about to expose her tumor to a new treatment that promises to completely eradicate the cancer. And they'll do in a couple of afternoons, outpatient only. With no anesthesia. And no side effects - none.
So far it's worked for tens of thousands of other cancer sufferers around the world. Maybe it will work for Karen.
After all, as one expert noted, an operation won't help an inoperable tumor.
Two brief inpatient treatments later she is cured. The tumor is completely gone. And Karen's vision is restored. She can see again. Her adoring husband, her beautiful son . . . he's grown so much in the years since she was robbed of her vision . . .
And his smile . . . that beautiful little boy's beaming smile fills the entire room.
Karen's story is true, by the way. Her hometown newspaper featured an extensive profile on her and the miracle tumor tracker.
"I wouldn't be alive today if it weren't for" this new technology and her doctors, Karen tells the local paper. "They quite simply saved my life."
That's how you change the world. Forever.
I'll send you my special report The Next Intuitive Surgical on this astonishing biotech miracle when you become a Quantum Confidential member.
Now, if you know me, you know I don't have a lot of patience for the bland, the generic, the kind of stock advice you might as well get in a fortune cookie or a newspaper horoscope.
Let's face it, nobody ever got rich following that kind of stock advice.
That's why I publish newsletters full of the rich, valuable, specific, inner-circle information proven to deliver money-making opportunities before the rest of the pack even has a clue.
As a Quantum Confidential member, you'll find out about the newest and brightest technology companies long before Wall Street or CNBC catch wind of them.
These guys are too late to the party with too little on the ball. By the time they get the word out to you, the money's been made.
In case you haven't figured it out yet, I love technology, but I love tech stocks more. That's why I launched Quantum Confidential - so I could share solid, money-making tech plays with readers who like to be out in front of the Street.
Let me give you a peek at some of the profitable "Sold" winners in our Quantum Confidential portfolio over the last two years.
Here's how a Quantum Confidential subscriber investing $10,000 in just a few of our winners would have made out:
Force Protection - Just last October ago, I recommended Force Protection, a company that makes vehicles resistant to the roadside bombs that endanger our troops. And these trucks couldn't have come at a better time.
As of July 2007, more than 3,500 U.S. troops have been killed in Iraq. And the majority of those deaths have been attributed to improvised explosive devices (IEDs). With that recommendation we not only got a very healthy return, but we also helped take our troops out of harm's way.
We bought Force Protection at $6.00 . . . and sold at $16.50. Our net: $17,505.50.
NVE Corp. - To say this nanotech leader has put a new spin on computer memory would be an understatement. Thanks to NVE, computer memory as you know it will soon be a distant memory itself.
NVE develops and sells devices that use "spintronics," a nanotechnology they helped pioneer. They're also a licensor of spintronic magnetic random access memory technology (MRAM), which has the potential to revolutionize electronic memory. This is real world-changing technology.
We bought NVE Corp. at $15.46 . . . and sold at $39.41. Our net: $13,961.28.
Ceramic Protection - Protection systems manufactured by Ceramic Protection make use of cutting-edge ceramic and fiber-reinforced composite technologies and are used by military, security and police forces throughout the world.
These folks build some of the best ballistic armor for our troops. This isn't just world-changing, it's possibly even world-saving.
We bought Ceramic Protection at $11.31 . . . and sold at $22.50. Our net: $9,890.
Novavax Inc. - This biotechnology company is changing the world by creating novel, highly potent vaccines for flu viruses - including "bird flu" - and portable manufacturing systems to rapidly deliver a customized vaccine in the midst of a pandemic.
This biotech groundbreaker could just be the solution to bioterror.
We bought Novavax at $4.00 . . . and sold at $6.75. Our net: $6,875.
SiRF Technologies - This world leader creates technologies that apply "location awareness" based on the Global Positioning System (GPS) to an ever-growing array of consumer products.
World-changing? You'll probably never have to ask a stranger for directions again.
We bought SiRF at $19.00 . . . and sold at $30.05. Our net: $5,806.30.
So add it up. Now check your answer.
That's right. If you had been a Quantum Confidential member and followed our advice on those five $10,000 plays alone, you would have pocketed a whopping $54,038.08.
That's right. Your $50,000 play would have returned $104,038.08. That's more than twice your initial investment!
Those are the kinds of results that put Quantum Confidential out in front of the rest of the tech stock pack.
Each week I'll bring you tech plays just like these, long before the rest of the world learns about them - capitalizing on their potential and converting their breakthrough technology into extraordinary money-making opportunities for you, time and time again.
And I'll do it by giving you fresh new stock updates every week, by email, that deal exclusively in select companies specializing in revolutionary, visionary products, services and technologies bringing the future into the present - from nanotech marvels to tumor-tracking cancer killers.
The result?
Incredible profit opportunities that fatten up your portfolio long before the fat cats catch wind of what we're up to.
Each of your Quantum Confidential updates will:
Give you clear, in-depth information behind each new pick so you can read the nitty-gritty of it all. You'll know exactly what each company does . . . the people running the show . . . their experience and vision . . . the cutting-edge products they're unleashing on the world . . . milestones achieved, milestones ahead, and how they'll get there from here . . . and most importantly, why the investment offers you such great profit potential.
Give you consistent, detailed updates on positions we currently hold. That's right. I don't just recommend plays - I invest in them right along with you.
Hand you recommendations so simple and easy to follow you could do them in your sleep. We'll make getting into and cashing out of plays so effortless it'll be like having your broker simply walk up and place cash in your hand.
Avoid the "Wealth Care" crisis and build for
rich and rewarding retirement
Get this report. Invest in this world-changing company. Pick some nice, secluded beach to build your McMansion. And to help you get there, I'm offering a very nice deal.
You see, a normal one-year membership to my money-making Quantum Confidential runs $600. That's just $50 a month - about the same as your cable bill without HBO and with plenty of ahead-of-the-pack stock plays.
I believe you deserve every opportunity to turn a tidy profit on this play. And that's why - if you join today - I'm offering one year of Quantum Confidential for just $479.
That's more than 20% off the normal subscription price - saving you over $120 that I want you to put back into buying up more of this portfolio-enriching biotech stock. But you have to sign up today.
Still not convinced? Let me sweeten the deal.
Quantum Confidential
Research Report
"The Next Intuitive Surgical"
Sign up today for two years and I'll knock $361 off the regular two-year subscription price of $1,200. Just $839 for two years of revolutionary, world-changing stock picks. That's 30 percent off. That's getting more than seven months of Quantum Confidential free.
$35.95 a month. A buck fifteen a day. You can't get a cup of coffee that you can actually drink for that.
One year, two years, it doesn't matter. You just have to ask yourself how much you want to make, and for how long. (I'd take the two years, but I like save money almost as much as I like making it.)
I am so confident you'll profit from Quantum Confidential that I'm not only offering you incredible discounts. I'm also guaranteeing your personal satisfaction, 100%.
Now, normally, I would insist that you agree 110% that Quantum Confidential is everything I promised and more, or cancel within the first 90 days for a full refund of your subscription - or anytime thereafter for a complete refund of the unused portion.
But not today. 90-day refund? Forget about it. You deserve better than that.
Here's the deal: If I fail in any way to satisfy you with the profits you're handed from our investment in this miraculous piece of visionary medical technology - or any other aspect of Quantum Confidential - at any time within a FULL YEAR, I'll cheerfully refund every penny you paid. And I'll insist you keep everything you've received without any cost or obligation.
"Your Recommendation Has Actually Saved My Portfolio!"
I doubt it'll ever come to that, though. Based on the satisfaction and loyalty of our current members, I'm sure you'll find Quantum Confidential one of your best-ever picks. Just like these readers did:
"Your thesis on the markets is spot on. Excellent. Regards." - E.J.
"Your recommendation has actually saved my portfolio! Thanks!" - Roger D.
"Here's how I'm doing with your recommendation. I purchased 5,000 shares at $5.80 per share. I'm doing quite well and kicking myself for not buying 10,000. Thanks!" - Don E.
"I am up 32% so far on this stock. Very pleasing given the market ups and downs! Keep 'em coming. Cheers." - Patrick
Look, the time to act on this play is now. I can't hold this offer out forever. I do not want you to miss out on one of the most spectacular money-making opportunities you'll run across this year.
Sign up for Quantum Confidential today. You'll get my free report, my exclusive tech stock picks, and a head start on the Street with every play. Just click on the Subscribe Now button below.
Like I said, I'm so sure you'll be completely satisfied I'll give you your money back if you're not, just as I described above, no questions asked.
But you have to act today. Please don't let this one pass you by. Subscribe now.
Yours in wealth, health and happiness,
Brian Hicks
P.S. Look, between us, no BS, you need to get in on this now. It's not going to stay out of the spotlight forever. Hospitals all over are dumping their headlock radiosurgical systems for these miracle tumor trackers because they can double or triple the number of cancer patients they treat. The company recently announced record revenues for fiscal 3Q 2007, up 129% from fiscal 3Q 2006. Sales are climbing. They've got a $559 million backlog. And that's not counting the new orders rolling in every day.
Please don't miss out in this. You'll never get a chance like it again. Subscribe to Quantum Confidential now. Get our special report, The Next Intuitive Surgical. Make almost unbelievable profits. And help save a life or two along the way. Who knows, maybe yours.
Brian
https://www.angelnexus.com/o/web/2393